The 2007 Canadian Hypertension Education Program recommendations: The scientific summary – an annual update

Campbell, Norm R.C.

doi:10.1016/s0828-282x(07)70796-1

Cited by 24 publications

(17 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hence, the risk associated with the (usually mild) short-term hypertension seen in this group of patients is unknown. The suggestions that follow are based on the chep guidelines and the clinical experience of the participating medical experts [24][25][26] . The chep guidelines have been published annually since 1999.…”

Section: Current Oncology-volume 19 Number 4 August 2012mentioning

confidence: 99%

Hypertension Management in Patients with Renal Cell Cancer Treated with Anti-Angiogenic Agents

et al. 2012

View full text Add to dashboard Cite

Inhibitors of the vascular endothelial growth factor (vegf-is) signalling pathway have fundamentally changed the treatment of metastatic renal cell carcinoma (mrcc). Hypertension is one of the most common side effects of vegf-is and has been reported with almost every vegf-i used for treatment to date. The exact mechanism of vegf-i–induced hypertension appears complex and multifactorial, and it remains to be fully explained. No randomized clinical trials are available to guide the management of hypertension during vegf-i treatment in mrcc patients. The guiding principles suggested here summarize the consensus of opinions on the diagnosis and management of vegf-i–induced hypertension during treatment of mrcc obtained from an expert working group composed of 4 Canadian medical oncologists and 5 Canadian hypertension specialists. The Canadian Hypertension Education Program guidelines, available literature, and expert opinion were used to develop the guiding principles.

show abstract

Section: Current Oncology-volume 19 Number 4 August 2012mentioning

confidence: 99%

Hypertension Management in Patients with Renal Cell Cancer Treated with Anti-Angiogenic Agents

et al. 2012

View full text Add to dashboard Cite

show abstract

“…24 Studies shown no association of compliance with age and sex, but for literacy. 25 The present study has shown significant increase in compliance scores of all study subjects as well as in case of compliant and non-compliant patients after educating the patients about hypertension (Table 2, Figure 1) 19,20,21,[26][27][28][29] One study however could not find significant effect of education of hypertensive patients through mailing education packets, on mildly uncontrolled hypertension, but significant improvement in patient knowledge, home monitoring and satisfaction was observed. 30 In our study one to one verbal communication in the language of the patient probably proved more beneficial in improving compliance.…”

Section: Discussionmentioning

confidence: 66%

“…Other studies have also shown the beneficial effect of improved and persistent compliance on uncontrolled hypertension or for adequate control of high blood pressure. 13,21,27,31 In one study family based home health education by trained lay health workers along with education of general practitioners was found to have significant reduction in blood pressure among hypertensive patients. 32 Less correlation of uncontrolled hypertensive patients with compliance was seen in one study in which 56% of uncontrolled patients were compliant and hence an improvement in the quality and efficacy of medical treatment was emphasized.…”

Section: Discussionmentioning

confidence: 99%

Impact of awareness about hypertension on compliance to antihypertensive medication

Gupta

Sood³

2018

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

INTRODUCTIONHypertension (defined as: systolic B.P.>=130mm Hg; diastolic B.P.>=80mm Hg) is a condition in which arterial B.P. is chronically elevated.1 It is the commonest cardiovascular disorder, posing a major public health challenge, a major risk factor for cardiovascular mortality and accounts for 20-50% of all deaths. 2 Raised blood pressure is responsible for 60% of strokes and 50% of coronary ABSTRACT Background: Hypertension, a common cardiovascular disorder accounts for 20-50% of all deaths. This risk can be greatly ameliorated by creating awareness about disease and its effective treatment alongside regular medical check-ups. Therapeutic failures result from patient non-compliance, manifested as intentional or unintentional errors in dosage or schedule, overuse or underuse of prescribed drugs and early termination of therapy. Adherence is helpful for management of hypertension and cost minimization. Non-adherence to the drug treatment is an important factor for uncontrolled hypertension and its complications. Methods: Patients were interviewed individually after taking informed consent, using pretested, predesigned, self-administered and closed ended questionnaire both before and 4 weeks after creating awareness about hypertension and its complications. Compliance measured by self-reporting in which knowledge of the patient about number of antihypertensive drugs being used, formulations of drugs, frequency of administration, duration of taking the drugs and knowledge of complications due to uncontrolled and untreated hypertension were assigned 1 score each. Patient having score of at least 4 out of total 5 was considered compliant. Results: No significant association of compliance with demographic and other variables like age, sex, marital status, economic status, education, urbanization, duration of treatment and drug procurement were noted. A significant increase in compliance in patients on antihypertensive medication was found 4 weeks after creating awareness about hypertension and its complication. A significant increase in compliance scores was also seen in non-compliant patients showing their shifting from non-compliance to compliance group. Overall compliance increased from 59.38% to 84.38%. A percentage decrease from 58.82% to 25% in patients having uncontrolled hypertension was also observed after the awareness about hypertension. Conclusions: Demographic variables, duration of hypertension and drug procurement have no significant effect on compliance to antihypertensive medication. There is persistence and improvement in compliance to antihypertensive medications after an education of the patients about hypertension and its complications.

show abstract

“…At the initial visit, body weight, height and waist circumference were measured and baseline medications were reviewed. Blood pressure (BP) measurements were performed in accordance with Canadian Hypertension Education Program recommendations (10). Laboratory investigations including a fasting lipid profile, fasting glucose, glycated hemoglobin (HbA1c), serum creatinine (to estimate glomerular filtration rate [eGFR]) and high-sensitivity C-reative protein (hsCRP) levels were performed by the primary care physician's local laboratory.…”

Section: Assessment Of Risk Factors and Cardiovascular Biomarkersmentioning

confidence: 99%

Acetylsalicylic acid use in primary prevention in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) study

Gupta¹,

Szmitko²

2016

Curr Res Cardiol

View full text Add to dashboard Cite

The 2007 Canadian Hypertension Education Program recommendations: The scientific summary – an annual update

Cited by 24 publications

References 61 publications

Hypertension Management in Patients with Renal Cell Cancer Treated with Anti-Angiogenic Agents

Hypertension Management in Patients with Renal Cell Cancer Treated with Anti-Angiogenic Agents

Impact of awareness about hypertension on compliance to antihypertensive medication

Acetylsalicylic acid use in primary prevention in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) study

Contact Info

Product

Resources

About